NRL Hunter matches are fun. They improve your skills, and they’re accessible to normal, everyday hunters. The rules and ...

When you rely on a rifle to protect your home or anchor a rural property, you are really betting on one thing: that it will ...

Old Republic International announced a special dividend of $2.50 per share. This news comes as multiple analysts upgraded the stock. For instance, Raymond James raised its rating to ‘strong-buy’.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings ...

On NATO’s Eastern Flank, low-grade Russian attacks are ramping up. WSJ’s Matthew Luxmoore goes inside Lithuania’s efforts to build defenses and train citizens for war as fears of a full-scale conflict ...

Josh Kohn-Lindquist is a contributing Motley Fool stock market analyst covering consumer goods, industrials, and technology stocks. Previously, Josh was a senior mutual fund accountant at Gemini Fund ...

Recently, analyst Mark Palmer from Benchmark raised the price target for Bitcoin-miner-turned-AI company Hut 8. The change in price target was due to the company’s latest push into AI data center ...

The CoreWeave logo is displayed on a mobile phone, with the company's branding visible in the background, in this photo illustration in Brussels, Belgium, on November 10, 2025. (Photo by Jonathan ...

Bristol-Myers Squibb Company (NYSE:BMY) is one of the Best Stocks to Invest in for the Next 3 Years. On December 15, BofA upgraded the company’s stock to “Buy” from “Neutral” with a price objective of ...

CoreWeave, Inc. (CRWV) has transitioned from a balance-sheet risk story into a leveraged beneficiary of the AI infrastructure build-out. While capital intensity and execution risk remain elevated, ...

Preformed Line Products stock seems to fly under the radar of many investors. The Ohio-based company is growing at a healthy clip, is profitable, has significant insider ownership, and maintains a ...

Recursion Pharmaceuticals (NASDAQ: RXRX) experienced an 11% increase in stock price on Wednesday after JP Morgan raised its rating, noting the promising potential of its MEK inhibitor program. However ...